Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF

Vaduganathan Muthiah; Claggett Brian L.; Desai Akshay S.; Anker Stefan D.; Perrone Sergio V; Janssens Stefan; Milicic Davor; Arango Juan L.; Packer Milton; Shi Victor C.; Lefkowitz Martin P.; McMurray John J. V; Solomon Scott D.

首页> 外文期刊>Journal of the American College of Cardiology >Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF

【24h】

Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF

机译：与HFPEF中的Valsartan相比，先前心力衰竭住院，临床结果和对Sacubitril / Valsartan的反应

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND The period shortly after hospitalization for heart failure (HF) represents a high-risk window for recurrent clinical events, including rehospitalization or death.

机译：背景技术心力衰竭住院后不久的时间（HF）代表了复发性临床事件的高风险窗口，包括再生或死亡。

著录项

来源
《Journal of the American College of Cardiology》 |2020年第3期|共10页
作者
Vaduganathan Muthiah; Claggett Brian L.; Desai Akshay S.; Anker Stefan D.; Perrone Sergio V; Janssens Stefan; Milicic Davor; Arango Juan L.; Packer Milton; Shi Victor C.; Lefkowitz Martin P.; McMurray John J. V; Solomon Scott D.;
展开▼
作者单位

Harvard Med Sch Brigham &

Womens Hosp Cardiovasc Div Boston MA 02115 USA;

Harvard Med Sch Brigham &

Womens Hosp Cardiovasc Div Boston MA 02115 USA;

Harvard Med Sch Brigham &

Womens Hosp Cardiovasc Div Boston MA 02115 USA;

German Ctr Cardiovasc Res Dept Cardiol Div Cardiol &

Metab Berlin Germany;

Inst Fleni Buenos Aires DF Argentina;

Univ Hosp Leuven Dept Cardiol Leuven Belgium;

Univ Hosp Ctr Zagreb Dept Cardiovasc Dis Zagreb Croatia;

Guatemalan Heart Inst Guatemala City Guatemala;

Baylor Univ Med Ctr Baylor Heart &

Vasc Inst Dallas TX USA;

Novartis Pharmaceut E Hanover NJ USA;

Novartis Pharmaceut E Hanover NJ USA;

Univ Glasgow British Heart Fdn Cardiovasc Res Ctr Glasgow Lanark Scotland;

Harvard Med Sch Brigham &

Womens Hosp Cardiovasc Div Boston MA 02115 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
clinical outcomes; heart failure with preserved ejection fraction; hospitalization; sacubitril/valsartan;

机译：临床结果;心力衰竭用保存的射血分数;住院治疗;Sacubitril / Valsartan;

相似文献

外文文献
中文文献
专利

1. The Effect of Sacubitril/Valsartan in a Dialysis Patient with Severe Heart Failure* [J] . Pingping Kong, Yanna Dou, Xiaoyang Wang, 临床医学病理报告（英文） . 2021,第007期
2. Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease? [J] . Yang CHEN, Lu-Ying GUO, Ling-Fei ZHAO, 老年心脏病学杂志（英文版） . 2020,第012期
3. Torsional Dynamics and 2D Speckle Tracking in Heart Failure with Reduced Ejection Fraction on Patients Taking Sacubitril/Valsartan and Naive [J] . Wassam EL Din EL Shafey, Walaa Faried, Mena Emad Shafek, 心血管病（英文） . 2020,第005期
4. Effect of sacubitril/valsartan on the expression of Gal-3 and MMP-9 in rabbits with cardiac hypertrophy [J] . Song-Chen Jiang, Shang-Yuan Gao, Fa-Jiang Xie, 海南医科大学学报（英文版） . 2019,第008期
5. Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF [J] . Vaduganathan Muthiah, Claggett Brian L., Desai Akshay S., Journal of the American College of Cardiology . 2020,第3期

机译：与HFPEF中的Valsartan相比，先前心力衰竭住院，临床结果和对Sacubitril / Valsartan的反应
6. Response by Jackson et al to Letter Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF" [J] . Circulation: An Official Journal of the American Heart Association . 2020,第1期

机译：杰克逊等人对文章的回应，“Sacubitril-valsartan与缬沙坦对女性的影响与患有心力衰竭和保存的喷射分数的男性相比：Paragon-Hf的见解”
7. Sacubitril/valsartan treatment improved the clinical outcome and reduced the hospitalization rate in three patients with chronic heart failure: a case series [J] . Donatella Severini, Kwame Mboumi Current medical research and opinion . 2019,第Suppla3期

机译：Sacubitril / Valsartan治疗改善了临床结果，并降低了三名慢性心力衰竭患者的住院率：案例系列
8. Effect of Valsartan Combined with Hydrochlorothiazide in the Treatment of Patients with Hypertensive Heart Disease [C] . Jing Bai, Yan Wang 2019 International Conference on Biology, Chemistry and Medical Engineering（ 2019年国际生物、化学和医学工程会议（ICBCME 2019）论文集 . -1

机译：缬沙坦联合盐酸血氮杂化的影响治疗高血压心脏病患者
9. Efficacy of Sacubitril/Valsartan in the Treatment of Women with Heart Failure with Preserved Ejection Fraction [D] . Lee, Rita Joyce. 2020

机译：Sacubitril / Valsartan在患有射血分数的心力衰竭治疗妇女的疗效
10. The Scope of Sacubitril/Valsartan Eligibility Post-Heart Failure Hospitalization: Findings from the Get With The Guidelines-Heart Failure Registry [O] . Kishan S. Parikh, Steven J. Lippmann, Melissa Greiner, -1

机译：心力衰竭住院后沙必比尔/缬沙坦资格的范围：指南-心力衰竭登记册中的发现
11. Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction [O] . John J.V. McMurray, Alice M. Jackson, Carolyn S.P. Lam, 2020

机译：Sacubitril-Valsartan对女性缬沙坦的影响与心力衰竭和保存射血分数的男性相比

Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF

摘要

著录项

相似文献

相关主题

期刊订阅